JP2002526472A5 - - Google Patents

Download PDF

Info

Publication number
JP2002526472A5
JP2002526472A5 JP2000574069A JP2000574069A JP2002526472A5 JP 2002526472 A5 JP2002526472 A5 JP 2002526472A5 JP 2000574069 A JP2000574069 A JP 2000574069A JP 2000574069 A JP2000574069 A JP 2000574069A JP 2002526472 A5 JP2002526472 A5 JP 2002526472A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000574069A
Other languages
Japanese (ja)
Other versions
JP2002526472A (ja
JP3926983B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/022013 external-priority patent/WO2000017159A1/en
Publication of JP2002526472A publication Critical patent/JP2002526472A/ja
Publication of JP2002526472A5 publication Critical patent/JP2002526472A5/ja
Application granted granted Critical
Publication of JP3926983B2 publication Critical patent/JP3926983B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000574069A 1998-09-23 1999-09-21 アリールスルホンアニリドウレア Expired - Fee Related JP3926983B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10088898P 1998-09-23 1998-09-23
US60/100,888 1998-09-23
PCT/US1999/022013 WO2000017159A1 (en) 1998-09-23 1999-09-21 Arylsulfonanilide ureas

Publications (3)

Publication Number Publication Date
JP2002526472A JP2002526472A (ja) 2002-08-20
JP2002526472A5 true JP2002526472A5 (US07585860-20090908-C00083.png) 2005-12-22
JP3926983B2 JP3926983B2 (ja) 2007-06-06

Family

ID=22282047

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000574069A Expired - Fee Related JP3926983B2 (ja) 1998-09-23 1999-09-21 アリールスルホンアニリドウレア

Country Status (24)

Country Link
US (3) US6214880B1 (US07585860-20090908-C00083.png)
EP (1) EP1115701B1 (US07585860-20090908-C00083.png)
JP (1) JP3926983B2 (US07585860-20090908-C00083.png)
KR (1) KR100642184B1 (US07585860-20090908-C00083.png)
CN (1) CN100335461C (US07585860-20090908-C00083.png)
AT (1) ATE240940T1 (US07585860-20090908-C00083.png)
AU (1) AU747663B2 (US07585860-20090908-C00083.png)
BR (1) BR9913903A (US07585860-20090908-C00083.png)
CA (1) CA2343204C (US07585860-20090908-C00083.png)
CZ (1) CZ2001934A3 (US07585860-20090908-C00083.png)
DE (1) DE69908156T2 (US07585860-20090908-C00083.png)
DK (1) DK1115701T3 (US07585860-20090908-C00083.png)
EA (1) EA003924B1 (US07585860-20090908-C00083.png)
ES (1) ES2194547T3 (US07585860-20090908-C00083.png)
HK (1) HK1038913A1 (US07585860-20090908-C00083.png)
HU (1) HUP0103884A3 (US07585860-20090908-C00083.png)
IL (2) IL142066A0 (US07585860-20090908-C00083.png)
NO (1) NO20011453L (US07585860-20090908-C00083.png)
NZ (1) NZ510435A (US07585860-20090908-C00083.png)
PL (1) PL198394B1 (US07585860-20090908-C00083.png)
PT (1) PT1115701E (US07585860-20090908-C00083.png)
SK (1) SK284757B6 (US07585860-20090908-C00083.png)
WO (1) WO2000017159A1 (US07585860-20090908-C00083.png)
ZA (1) ZA200102033B (US07585860-20090908-C00083.png)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9508644D0 (en) * 1995-04-28 1995-06-14 Exxon Chemical Patents Inc Fuel compositions
IL142066A0 (en) * 1998-09-23 2002-03-10 Tularik Inc Arylsulfonanilide urea derivatives and pharmaceutical compositions containing the same
US6316503B1 (en) * 1999-03-15 2001-11-13 Tularik Inc. LXR modulators
EP1206256B8 (en) * 1999-07-29 2005-06-29 Amgen, Inc. Combination therapy using pentafluorobenzenesulfonamide and platin compound
US6664259B2 (en) 2000-03-16 2003-12-16 Smithkline Beecham Corporation Il-8 receptor antagonists
CO5280089A1 (es) * 2000-03-16 2003-05-30 Smithkline Beecham Corp Antagonistas del receptor il-8
UY26627A1 (es) 2000-03-24 2001-09-28 Smithkline Beecham Corp Antagonistas de receptores de il-8
WO2002020463A2 (en) * 2000-09-05 2002-03-14 Tularik Inc. Fxr modulators
AU2002234165A1 (en) 2000-11-03 2002-05-27 Tularik, Inc. Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
US20050250854A1 (en) * 2000-11-03 2005-11-10 Amgen Inc. Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
IL157540A0 (en) 2001-02-28 2004-03-28 Univ Temple N-(aryl)-2-arylethenesulphonamides and therapeutic uses thereof
AUPR738301A0 (en) * 2001-08-30 2001-09-20 Starpharma Limited Chemotherapeutic agents
DE60324104D1 (en) * 2002-01-30 2008-11-27 Amgen Inc Arylsulfonamidobenzylverbindungen
EP1476425A4 (en) * 2002-01-30 2010-05-05 Amgen Inc Heterocyclic Aryl Sulphonamidocyclic Compounds
ATE517626T1 (de) 2002-02-28 2011-08-15 Univ Temple Aminosubstituierte sulphonanilide und ihre derivate zur behandlung von proliferativen erkrankungen
AR041834A1 (es) * 2002-10-29 2005-06-01 Smithkline Beecham Corp Compuesto de difenilurea sustituido con sulfonamida, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion
WO2005016277A2 (en) * 2003-08-12 2005-02-24 Amgen Inc. Arylsulfonamidobenzylic compounds
US20050124664A1 (en) * 2003-10-30 2005-06-09 Eric Sartori Urea thiadiazole inhibitors of plasminogen activator inhibior-1
US20050154455A1 (en) * 2003-12-18 2005-07-14 Medtronic Vascular, Inc. Medical devices to treat or inhibit restenosis
US20050261762A1 (en) * 2004-05-21 2005-11-24 Medtronic Vascular, Inc. Medical devices to prevent or inhibit restenosis
US20060062822A1 (en) * 2004-09-21 2006-03-23 Medtronic Vascular, Inc. Medical devices to treat or inhibit restenosis
US20070027530A1 (en) * 2005-07-26 2007-02-01 Medtronic Vascular, Inc. Intraluminal device, catheter assembly, and method of use thereof
FI20055498A0 (fi) * 2005-09-16 2005-09-16 Biotie Therapies Corp Sulfonamidijohdannaisia
US20070067020A1 (en) * 2005-09-22 2007-03-22 Medtronic Vasular, Inc. Intraluminal stent, delivery system, and a method of treating a vascular condition
MX2008013599A (es) * 2006-04-21 2008-10-31 Smithkline Beechman Corp Antagonistas del receptor il-8.
US20090093451A1 (en) * 2006-04-21 2009-04-09 Smithkline Beecham Corporation IL-8 Receptor Antagonists
EP2094268A2 (en) * 2006-05-26 2009-09-02 Bayer HealthCare, LLC Drug combinations with substituted diaryl ureas for the treatment of cancer
PE20080943A1 (es) * 2006-06-23 2008-09-27 Smithkline Beecham Corp Sal toluenosulfonato de 4-{[6-cloro-3-({[(2-cloro-3-fluorofenil)amino]carbonil}amino)-2-hidroxifenil]sulfonil}-1-piperazinacarboxilato de 1,1-dimetiletilo como antagonista del receptor de il-8
US8252841B2 (en) * 2007-10-19 2012-08-28 The Board Of Regents Of The University Of Texas System Methods of inhibiting bacterial virulence and compounds relating thereto
EP2385831A4 (en) * 2009-01-09 2014-03-26 Uab Research Foundation SMALL MOLECULAR HEMMER OF NADS, NAMNAT AND NMNAT
US9518011B2 (en) 2012-11-21 2016-12-13 Nippon Soda Co., Ltd. Recording material produced using non-phenol compound
US9444712B2 (en) 2012-11-21 2016-09-13 Cisco Technology, Inc. Bandwidth on-demand services in multiple layer networks
JPWO2017170826A1 (ja) * 2016-03-30 2019-02-14 味の素株式会社 グルカゴン様ペプチド−1受容体作用増強活性を有する化合物

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1955207A (en) 1931-09-16 1934-04-17 Ig Farbenindustrie Ag Mothproofing agent
DE622494C (de) 1932-01-03 1935-11-29 I G Farbenindustrie Akt Ges Verfahren zur Darstellung von Mono- bzw. Polynitropolysulfonen und deren Reduktionsprodukten
US2358365A (en) 1940-08-03 1944-09-19 Parke Davis & Co Sulphonamide derivatives and process for obtaining the same
US2402623A (en) 1943-06-24 1946-06-25 Rohm & Haas Nu-nitroaryl haloarylsulphonamides
CH361275A (de) 1957-09-10 1962-04-15 Geigy Ag J R Verfahren zur Herstellung von neuen Arylsulfonarylamiden
GB938890A (en) 1961-02-03 1963-10-09 Boots Pure Drug Co Ltd New fungicidal compositions and compounds
CH504416A (de) 1966-12-05 1971-03-15 Ciba Geigy Ag Verfahren zur Herstellung von aromatischen Sulfamoylverbindungen
GB1242057A (en) 1968-07-04 1971-08-11 Ici Ltd Derivatives of 4-hydroxytetrafluoropyridine and the use thereof as plant growth regulators
NL174644C (nl) 1970-04-13 1984-07-16 Minnesota Mining & Mfg Werkwijze ter bereiding van een herbicide verbinding; tevens werkwijze voor de bereiding van een preparaat met herbicide werking.
FR2456731A1 (fr) 1979-05-16 1980-12-12 Choay Sa Nouveaux derives substitues d'ary
DE3623184A1 (de) 1986-07-10 1988-01-14 Kali Chemie Ag Verfahren zur herstellung von n-fluorsulfonamiden
US4883914A (en) 1987-08-17 1989-11-28 American Cyanamid Company Benzenesulfonyl carboxamide compounds useful as herbicidal agents
DE3804990A1 (de) 1988-02-18 1989-08-31 Basf Ag Herbizid wirksame, heterocyclisch substituierte sulfonamide
DE3905075A1 (de) 1989-02-18 1990-08-30 Hoechst Ag Benzolsulfonamide und verfahren zu ihrer herstellung
FR2645537B1 (fr) 1989-04-05 1994-03-04 Fabre Medicament Pierre Nouveaux sulfonamides derives d'acides benzocycliques ou benzoheterocycliques, leur preparation et leur application en therapeutique
FR2665440B1 (fr) 1990-07-31 1994-02-04 Lipha Nouveaux cycloalkylsulfonamides substitues, procedes de preparation et medicaments les contenant.
US5189211A (en) 1990-08-01 1993-02-23 Taisho Pharmaceutical Co., Ltd. Sulfonamide derivatives
DE69129611T2 (de) 1990-08-20 1998-12-17 Eisai Co Ltd Sulfonamid-Derivate
US5780483A (en) * 1995-02-17 1998-07-14 Smithkline Beecham Corporation IL-8 receptor antagonists
EP0896533B1 (en) * 1996-02-22 2003-09-10 Tularik, Inc. Pentafluorobenzenesulfonamides and analogs
AU710173B2 (en) * 1996-07-19 1999-09-16 Tularik Inc. Pentafluorobenzenesulfonamides and analogs
WO1999024407A1 (en) 1997-11-10 1999-05-20 Array Biopharma, Inc. Compounds which inhibit tryptase activity
ES2234169T3 (es) 1997-12-23 2005-06-16 Warner-Lambert Company Llc Compuestos de tiourea, composiciones y procedimientos de tratamiento o prevencion de enfermedades inflamatorias y ateroesclerosis.
IL142066A0 (en) * 1998-09-23 2002-03-10 Tularik Inc Arylsulfonanilide urea derivatives and pharmaceutical compositions containing the same
EP1206256B8 (en) * 1999-07-29 2005-06-29 Amgen, Inc. Combination therapy using pentafluorobenzenesulfonamide and platin compound

Similar Documents

Publication Publication Date Title
BE2018C020I2 (US07585860-20090908-C00083.png)
BE2015C057I2 (US07585860-20090908-C00083.png)
BE2016C007I2 (US07585860-20090908-C00083.png)
BE2015C018I2 (US07585860-20090908-C00083.png)
BE2014C017I2 (US07585860-20090908-C00083.png)
BE2013C051I2 (US07585860-20090908-C00083.png)
BE2013C020I2 (US07585860-20090908-C00083.png)
BE2013C015I2 (US07585860-20090908-C00083.png)
BE2013C001I2 (US07585860-20090908-C00083.png)
BE2012C036I2 (US07585860-20090908-C00083.png)
BE2011C004I2 (US07585860-20090908-C00083.png)
BE2010C011I2 (US07585860-20090908-C00083.png)
BE2008C046I2 (US07585860-20090908-C00083.png)
BE1025464I2 (US07585860-20090908-C00083.png)
BRPI0017527B8 (US07585860-20090908-C00083.png)
BE2008C047I2 (US07585860-20090908-C00083.png)
BRPI0001672A2 (US07585860-20090908-C00083.png)
JP2002526174A5 (US07585860-20090908-C00083.png)
BRPI0001542A2 (US07585860-20090908-C00083.png)
JP2002524888A5 (US07585860-20090908-C00083.png)
JP2002521420A5 (US07585860-20090908-C00083.png)
JP2002516548A5 (US07585860-20090908-C00083.png)
BRPI0012675B8 (US07585860-20090908-C00083.png)
BRPI0017522A2 (US07585860-20090908-C00083.png)
HU0004351D0 (US07585860-20090908-C00083.png)